Lucefite Eye Drops (Olopatadine Hydrochloride)
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
CMG Pharmaceutical Co., Ltd.
MFDS item code 201704543 · Approved 2017.06.21 · Insurance code 648603491
Relief of symptoms associated with allergic conjunctivitis
This medication is used to relieve symptoms such as itching, redness, and tearing of the eyes caused by allergic conjunctivitis. It helps reduce allergic reactions and improves discomfort in the eyes, allowing for normal daily activities.
Instill 1 drop 2 times a day (at 6-8 hour intervals). If necessary, treatment may continue for up to 4 months.
This medication should not be used by patients who have allergic reactions to the active ingredient or any other components. Neurological symptoms such as headache, altered taste, and dizziness may occur when using this medication. Eye-related side effects may include punctate keratitis, keratitis, ocular pain, dry eyes, eyelid edema, itching of the eyes, eye discharge, eye redness, eyelid keratinization, and discomfort in the eyes. Occasionally, glare, blurred vision, and eyelid erythema have also been reported. Dryness of the nasal passages or symptoms of rhinitis may occur, and mouth dryness may also happen. Contact dermatitis may appear on the skin, and fatigue may be experienced. Using this medication may rarely lead to increased eye hypersensitivity, weakness, cold symptoms, nausea, pharyngitis, sinusitis, skin erythema, abdominal pain, liver dysfunction, jaundice, increased blood pressure, decreased white blood cells and lymphocytes, renal dysfunction, and difficulty urinating. This medication contains phosphates, which can lead to corneal calcification very rarely in patients with severe corneal damage; caution is required. This medication is a non-sedating antihistamine, and temporary blurring of vision may occur after use; therefore, one should wait until vision is clear before driving or operating machinery. Patients who are on long-term steroid therapy should gradually reduce the steroid dosage under medical supervision while using this medication. Patients with seasonal allergies are advised to start this medication before the season when symptoms appear and to use it consistently until symptoms resolve. Care should be taken not to use it long-term if ineffective. The benzalkonium chloride present in this medication may cause eye irritation and discoloration of soft contact lenses, so lenses should not be worn for at least 15 minutes after administration. It is advisable to avoid wearing contact lenses when the eyes are red. Pregnant women should use this medication cautiously, as its safety for the fetus has not been sufficiently established, and should rely on a doctor's judgment. Breastfeeding women should also consult a doctor before use, as some components of this medication may be excreted in breast milk. The safety and effectiveness in children under 3 years of age have not been established, so caution is required. No specific dosage adjustment is needed for elderly patients. This medication is an eye drop for local use only and should not be taken orally or by injection; care should be taken to avoid contamination by keeping the tip of the container from coming into contact with the eye or hands. When using other eye drops, allow at least 5 minutes between applications, and ointments should be administered last. When not in use, always close the bottle cap tightly, keep it out of direct sunlight, and store it in a cool place. Keep it out of reach of children and do not transfer it to another container.
Hypersensitivity (severe allergic reaction), jaundice, difficulty urinating
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that blocks light and allows good ventilation, preferably at room temperature between 4 degrees to 25 degrees Celsius. Proper storage can help maintain the effectiveness of the medication over time.
The eye drops are a colorless to pale yellow, opaque liquid contained in a white plastic bottle.
6mL/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
CMG Pharmaceutical Co., Ltd.
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.
Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Korea Kyowa Kirin Co., Ltd.
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.